Two new changes to CMS' ACO Investment Model will help practices in rural areas gain more access to the benefits of accountable care organizations.
Two new changes to CMS’ ACO Investment Model will help practices in rural areas gain more access to the benefits of accountable care organizations (ACOs).
The modifications will allow ACOs currently participating in the Medicare Shared Savings Program to apply in the next application round, and will remove the criteria that requires rural ACOs have 10,000 or fewer assigned beneficiaries for ACOs that started in the program in 2015 (or will start in 2016).
“These two changes reflect the Innovation Center’s commitment to listening to suggestions and ensuring that demonstrations are widespread, including rural providers and smaller physician groups,” Patrick Conway, MD, deputy administrator of innovation and quality and chief medical officer of CMS, wrote in a blog post.
The ACO Investment Model will provide $114 million in upfront investments to up to 75 ACOs across the country. The model was developed to encourage new ACOs to form in rural and underserved areas. Providers in rural areas have felt it is tough for them to participate in the ACO program because of the high startup costs.
“Through the CMS Innovation Center, this initiative will provide upfront and ongoing investments in infrastructure and redesigned care process to help eligible ACOs continue to provide higher quality care,” wrote Dr Conway. “This will help increase the number of beneficiaries that can benefit from lower costs and improved health care through Medicare ACOs.”
Trump Administration’s Message to Supreme Court Puts New Wrinkle in Braidwood Case
February 21st 2025The Trump administration argues that HHS Secretary Robert F. Kennedy Jr can overrule the US Preventive Services Task Force to determine the preventive services covered under the Affordable Care Act.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
5 Key Health Care Moments During President Trump's First Month Back in Office
February 21st 2025President Donald J. Trump pushed for significant health care changes during his first month back in office, through executive orders affecting managed care, drug pricing, and clinical trial diversity guidance.
Read More
Abortion in 2025: Access, Fertility, and Infant Mortality Updates
February 20th 2025While Republican state-led efforts aim to increase restrictions to abortion care and access to mifepristone and misoprostol in 2025, JAMA authors join the conversation with their published research and commentary.
Read More